Lund, September 9th, 2014
For release 4:00 p.m. CET, 10:00 a.m. EST, September 9th, 2014
TFS Appoints Nigel Jones as Vice President, Global Clinical Development
TFS is pleased to announce the appointment of Nigel Jones as Vice President, Global Clinical Development. This new appointment will further strengthen the TFS global organization. Nigel will be responsible for supporting the strategic and operational initiatives within Global Clinical Development at TFS to maximize process efficiency and assure excellence in operational delivery, and for leading and providing oversight and governance for key customer partnerships.
Nigel brings over 25 years of clinical development experience to TFS, gained from leading global CROs and biopharmaceutical companies. Nigel joins from Auxilium Pharmaceuticals where he spent the last 14 years having responsibility for the company’s product development pipeline in the International region and more recently at the global level. He brings a wealth of experience in clinical development, leadership of high achieving multinational project teams and working seamlessly with alliance partners and key opinion leaders to support product development and market launch activity. His therapeutic expertise is focused in the areas of anti-infectives, urology/men’s health, orthopedics, aesthetics and biologicals.
"I have worked with TFS as a customer since 2006 and was always impressed with the motivation and professionalism of the personnel and their willingness to partner and to go the extra distance to ensure that project objectives and deliverables were met. There is a very strong emphasis on customer service within the organization and in providing excellence in project delivery. This starts at the very top of the organization with the executive management team of highly customer-focused individuals who lead by example. I am really looking forward to being able to share my global development experience with an organization that is committed to their customers and in exceeding customer expectations”, says Mr. Nigel Jones, Vice President, Global Clinical Development.
“We are proud that Nigel Jones has joined the TFS group. He brings with him a wealth of experience which will add great value to us and will further strengthen our operational excellence”, says Ms. Thea Wesseling, Executive Vice President, Global Clinical Development.
For further information please contact:
Ms. Gordana Clavères
Marketing and Communications Assoc.